~667 spots leftby Jun 2029

School Clinician Training Program for ADHD

((CLS-A-FUERTE) Trial)

Recruiting in Palo Alto (17 mi)
+2 other locations
Overseen ByLauren Haack, PhD
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of California, San Francisco
No Placebo Group

Trial Summary

What is the purpose of this trial?Neurodevelopmental disorders of Attention-Deficit/ Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD) are extremely common but underserved with Evidence- Based Treatments (EBT) worldwide. Thus, a school clinician training and ADHD/ODD intervention (i.e., the Collaborative Life Skills \[CLS\] program) was developed, implemented and evaluated for Mexico: a setting with high unmet need. Technology was integrated into the in-person program (CLS-FUERTE) to create a digitally enhanced version (CLS-R-FUERTE). Given findings demonstrating feasibility, acceptability, and efficacy of both program versions, a Type 2 Hybrid Effectiveness-Implementation Design will be applied to evaluate the program effectiveness, mechanisms of intervention change, and maintenance barriers/facilitators in a scaled-up cluster randomized controlled trial across two Mexican states -while simultaneously exploring an implementation strategy in which the program is adapted to enhance maintenance given each school's needs/resources (i.e., CLS-A-FUERTE). The implementation process is guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) model with evaluation following the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) Framework.

Eligibility Criteria

This trial is for students with ADHD/ODD in Mexico. School clinicians will be trained to implement the CLS-A-FUERTE program, which includes digital enhancements and adaptations based on school resources. Students must attend participating schools where this new approach will be compared to usual school services.

Inclusion Criteria

My medication has been the same for a while.
Students meeting the following criteria are eligible: at least six inattention symptoms and/or six hyperactive/impulsive symptoms endorsed by parent or teacher as occurring often or very often, at least one area of impairment rated as concerning by both parent and teacher, and a parent and teacher agreeing to participate
Parents and teachers and school clinicians of participating are eligible to participate

Exclusion Criteria

Child Participants: Children taking medication will be eligible for screening after the child has been on a stable medication regimen for at least one month (to minimize chance that treatment effects are due to medication and not the proposed program), Presence of conditions that are incompatible with this study's treatment: severe visual or hearing impairment, severe language delay, psychosis, Child does not read or speak Spanish (inability to complete assessment measures or participate in group treatments), Child is in an all-day special education classroom. Children in these classrooms are frequently receiving intensive behavior modification programs and assistance such that the teacher consultation component would be expected to require modification for use in these settings.
I speak and read Spanish fluently.

Participant Groups

The effectiveness of the CLS-A-FUERTE training and intervention program for ADHD/ODD is being tested across Mexican schools. The study aims to see if students improve more with this program than with standard care, and how well teachers and families can engage with it.
2Treatment groups
Experimental Treatment
Active Control
Group I: CLS-A-FUERTEExperimental Treatment1 Intervention
Receiving the CLS-A-FUERTE program immediately
Group II: School Services as Usual (SA)Active Control1 Intervention
Receiving School Services as Usual while waiting to receive the CLS-A-FUERTE program in the subsequent schoolyear

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
UCSFSan Francisco, CA
Loading ...

Who Is Running the Clinical Trial?

University of California, San FranciscoLead Sponsor
Fogarty International Center of the National Institute of HealthCollaborator

References